H. Buening

Chemotherapeutic agents enhance AAV2-mediated gene transfer into breast cancer cells promoting CD40 ligand-based immunotherapy

R. Kreienberg, M. Hallek, H. Deissler, 2006, Journal of Cancer Research and Clinical Oncology.

Gene transfer preferentially selects MHC class I positive tumour cells and enhances tumour immunogenicity

M. Hallek, D. Kofler, U. Hacker, 2006, Cancer Immunology, Immunotherapy.

Exploring Different Serotypes And Promoters In rAAV-mediated Gene Replacement Therapy Of Achromatopsia Type 2 (ACHM2)

N. Tanimoto, S. Beck, M. Seeliger, 2011 .

Transductional and transcriptional targeting of cancer cells using genetically engineered viral vectors.

G. Nemerow, M. Hallek, P. Reynolds, 2003, Cancer letters.

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells.

M. Hallek, R. Ali, A. Thrasher, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Efficient gene transfer to periodontal ligament cells and human gingival fibroblasts by adeno-associated virus vectors.

M. Hallek, L. Perabò, A. Huber, 2009, Journal of dentistry.